ReviewDetermination of maternal-fetal biomarkers of prenatal exposure to ethanol: A review
Highlights
► A complete review of assay methods to determine maternal-fetal biomarkers of prenatal exposure to ethanol is presented. ► Methods to determine derivatives of non-oxidative ethanol metabolism in maternal and neonatal biological matrices are reported. ► Assays for classical biomarkers of alcohol-induced are also included.
Introduction
Alcohol is the most popular legal drug used in our times, and its consumption by women of reproductive age remains a significant public health concern. The adverse effects of drinking in pregnancy have been well documented. Gestational alcohol use can result in a continuum of adverse fetal outcomes known as fetal alcohol spectrum disorder (FASD) [1], which encompasses distinctive craniofacial dysmorphology, growth retardation, and neurodevelopmental and cognitive deficits [2]. FASD may be as prevalent as 1% of live births and the affected person has increased risk for a wide range of mental disorders and social impairments over the entire lifespan [3]. Moreover, FASD is one of the most recurrent and at the same time easily preventable developmental disorder [4].
Another aspect to consider is the cost of caring for children and adults with FASD. In North Dakota, the mean annual cost of health care for a child with FAS from birth through 21 years of age was $2,342 more compared to a child without FAS [5]. Current cost includes health care, foster care, treatment for developmental disabilities, early intervention programs, special education, mental health, substance abuse treatment, for the most affected persons care for their entire adult life, and the cost of the corrections system including juvenile justice [6].
Currently, detection of prenatal alcohol exposure is based on maternal report, or suspicion of it based on history (lack of prenatal care, alcohol related life events, abuse, and alcohol impaired driving infractions). Until know, the only tools to obtain information about prenatal alcohol exposure have been questionnaires and interviews of the mother [7]. However, one of the major disadvantages of self-reports is that women tend to underreport the amount and frequency of their alcohol intake and they are reluctant to reveal gestational alcohol use, because the stigma and fear of punishment [8].
Thus, due to the difficulty in assessing alcohol-drinking behaviour from an objective point of view, in the last decades a number of biological markers considered far more reliable for documenting ethanol use have been introduced and validated. These biomarkers include direct measurements of ethanol and measurements of the products of oxidative and non-oxidative ethanol metabolism (Fig. 1).
We report on the “state of the art” of the methodology for testing maternal and fetal biomarkers of prenatal exposure to ethanol. The analytical procedures are summarized in Table 1.
Section snippets
Indirect maternal biomarkers
The clinical parameters used routinely for diagnosis of chronically high alcohol use are indirect markers, such as the liver enzymes gamma-glutamyltransferase (GGT), aspartate aminotransferase (AST), alanine aminotransferase (ALT), mean corpuscular erythrocyte volume (MCV), or carbohydrate-deficient transferrine (CDT). Moreover, there are also certain low-molecular-weight indirect markers, such as the plasma ratio of 5-hydroxytryptophol/5-hydroxyindolylacetic acid (5-HTOL/5-HIAA) which changes
Direct biomarkers
Direct alcohol markers are chemically derived from the ethanol molecule and contain still the two carbon atoms of ethanol. These are ethanol itself or metabolites of ethanol such as fatty acid ethyl esters (FAEEs), ethyl glucuronide (EtG), or phosphaditylethanol (PEth). Concerning ethanol itself, it is usually measured in breath and blood, although to detect only very recent single drinking occasion and thus useless to eventually assess gestational use and consequent prenatal exposure to this
Conclusions and perspectives
The fetal, neonatal and maternal matrices are, to different extent, repositories of substances, among them ethanol and its biomarkers to which the fetus is exposed in utero.
Therefore the accurate assessment of fetal exposure to ethanol through the use of these objective biomarkers, could be of major importance since it provides the basis for appropriate treatment and adequate follow-up of exposed newborns. Whereas indirect maternal biomarkers are only indicative of chronic maternal alcohol use
Acknowledgement
This study was supported by a grant of the Plan Nacional Sobre Drogas (2008/085) from the Ministerio de Sanidad y Consumo (Spain).
References (138)
- et al.
Fetal alcohol syndrome prevention: annual and cumulative cost saving
Neurotoxicol. Teratol.
(2003) - et al.
Gamma-glutamyl transpeptidase in chronic alcoholism
Lancet
(1970) - et al.
Detection of alcohol consumption during pregnancy – current and future biomarkers
Neurosci. Biobehav. Rev.
(2007) - et al.
Changes in transferrin glycosylation during pregnancy may lead to false-positive carbohydrate-deficient transferrin (CDT) results in testing for riskful alcohol consumption
Clin. Chim. Acta
(2011) - et al.
Urinary 5HTOL/5HIAA as biochemical marker of postmortem ethanol synthesis
Lancet
(1992) - et al.
Determination of glucuronidated 5-hydroxytryptophol (GTOL), a marker of recent alcohol intake, by ELISA technique
Clin. Biochem.
(2007) - et al.
Modification of proteins and other biological molecules by acetaldehyde: adduct structure and functional significance
Int. J. Biochem.
(1992) - et al.
Studies of whole blood-associated acetaldehyde levels in teetotalers
Alcohol
(1993) - et al.
Improved method for acetaldehyde in plasma and hemoglobin-associated acetaldehyde: results in teetotalers and alcoholics reporting for treatment
Alcohol
(1987) - et al.
The prenatal detection of significant alcohol exposure with maternal blood markers
J. Pediatr.
(1998)
Fatty acid ethyl esters are present in human serum after ethanol ingestion
J. Lipid Res.
Rapid separation of lipid classes in high yield and purity using bonded phase columns
J. Lipid Res.
Fatty acid ethyl esters: markers of alcohol abuse and alcoholism
Alcohol
Squalene in hair – a natural reference substance for the improved interpretation of fatty acid ethyl ester concentrations with respect to alcohol misuse
Forensic Sci. Int.
Purification of fatty acid ethyl esters by solid-phase extraction and high-performance liquid chromatography
J. Chromatogr. B. Biomed. Appl.
Fatty acid ethyl esters in meconium: biomarkers for the detection of alcohol exposure in neonates
Clin. Chim. Acta
Validation of a new biomarker of fetal exposure to alcohol
J. Pediatr.
Detection and quantification of fatty acid ethyl esters in meconium by headspace-solid-phase microextraction and gas chromatography–mass spectrometry
J. Chromatogr. B. Anal. Technol Biomed. Life Sci.
An improved method for rapidly quantifying fatty acid ethyl esters in meconium suitable for prenatal alcohol screening
Alcohol
Liquid chromatography–tandem mass spectrometry for fatty acid ethyl esters in meconium: assessment of prenatal exposure to alcohol in two European cohorts
J. Pharm. Biomed. Anal.
Fatty acid ethyl esters in meconium are associated with poorer neurodevelopmental outcomes to two years of age
J. Pediatr.
State of the art in hair analysis for detection of drug and alcohol abuse
Clin. Chim. Acta
Improvement of ethyl glucuronide determination in human urine and serum samples by solid-phase extraction
J. Chromatogr. B Biomed. Sci. Appl.
Identifying maternal self-reported alcohol use associated with fetal alcohol spectrum disorders
Alcohol Clin. Exp. Res.
Development and psychopathology fetal alcohol syndrome and related conditions
Semin. Clin. Neuropsychiatry
Risk factors for adverse life outcomes in fetal alcohol syndrome and fetal alcohol effects
J. Dev. Behav. Pediatr.
Prevention of alcohol abuse-related birth effects – I. Public education efforts
Alcohol Alcohol
Cost of fetal alcohol spectrum disorders
Am. J. Med. Genet. C. Semin. Med. Genet.
Alcohol-screening instruments for pregnant women
Alcohol Res. Health
Detecting risk drinking during pregnancy: a comparison of four screening questionnaires
Am. J. Public Health
Dose response of laboratory markers to alcohol consumption in a general population
Am. J. Epidemiol.
Determinants of gamma-glutamyltransferase: positive interaction with alcohol and body mass index, negative association with coffee
Am. J. Epidemiol.
Development of radioimmunoassay for gamma-glutamyl transferase using pancreatic enzyme
Ann. Clin. Biochem.
Prevention of fetal alcohol effects. An antenatal program for early detection of pregnancies at risk
Acta Obstet. Gynecol. Scand.
Gamma-glutamyltransferase, aspartate and alanine aminotransferases and their ratio, mean cell volume and urinary dolichol in pregnant alcohol abusers
Br. J. Obstet. Gynaecol.
Alcohol intake and liver function tests
Ann. Clin. Biochem.
Laboratory testing for recent alcohol consumption: comparison of ethanol, methanol, and 5-hydroxytryptophol
Clin. Chem.
Optimization of methods for aspartate aminotransferase and alanine aminotransferase
Clin. Chem.
Review of pyridoxal phosphate and the transaminases in liver disease
Ann. Clin. Lab. Sci.
Evaluation of abnormal liver-enzyme results in asymptomatic patients
N. Engl. J. Med.
Macrocytosis of chronic alcoholism
Lancet
Traditional markers of excessive alcohol use
Addiction
Persistent macrocytosis following abstinence from chronic alcohol use
JAMA
Comparing the diagnostic accuracy of carbohydrate-deficient transferrin, gamma-glutamyltransferase, and mean cell volume in a general practice population
Alcohol Clin. Exp. Res.
High mean red cell volume: its incidence and significance in routine haematology
J. Clin. Pathol.
Mean cell volume and gamma-glutamyl transferase are superior to carbohydrate-deficient transferrin and hemoglobin-acetaldehyde adducts in the follow-up of pregnant women with alcohol abuse
Acta Obstet. Gynecol. Scand.
CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project
Alcohol Clin. Exp. Res.
Recommendations on use of biomarkers in alcoholism treatment trials
Alcohol Clin. Exp. Res.
Intra- and interindividual variability of carbohydrate-deficient transferrin, and gamma-glutamyltransferase, and mean corpuscular volume in teetotalers
Clin. Chem.
Analysis of carbohydrate-deficient transferrin: comparative evaluation of turbidimetric immunoassay, capillary zone electrophoresis, and HPLC
Clin. Chem.
Cited by (99)
Predictive risk markers in alcoholism
2023, Advances in Clinical ChemistrySensitive and reliable gas chromatography tandem mass spectrometry assay for ethyl glucuronide in neonatal meconium
2019, Journal of Pharmaceutical and Biomedical AnalysisAlcohol biomarkers: Clinical issues and analytical methods
2019, Critical Issues in Alcohol and Drugs of Abuse TestingMeconium biomarkers of prenatal alcohol exposure
2019, Neuroscience of Alcohol: Mechanisms and Treatment